A Fast, Clear Path to Clinical Validation
Our initial clinical focus is Raynaud’s syndrome, a highly prevalent, painful vascular condition that affects blood flow in fingers and toes. It causes recurrent spasms, numbness, and color changes in response to cold or stress—and significantly impacts quality of life.
Why start with Raynaud?
Clear, measurable clinical outcomes
Relatively fast and cost-efficient proof-of-concept
No registered treatment
Attractive commercial market (>€500M peak sales)
Success here will pave the way for broader cardiovascular indications.
